Trial intelligence / Profile preview

Ondansetron for prevention of hypotension after spinal anesthesia

IRCT20201006048947N1Phase 3Completed

Sponsor
Jahrom University of Medical Sciences
Start
Oct 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of ondansetron in hypotension induced by spinal anesthesia (2 arms), sponsored by Jahrom University of Medical Sciences. Primary endpoint: Percentage of people with low blood pressure. Started Oct 2020; status: completed.

02

Drugs

ondansetron
03

Conditions

hypotension induced by spinal anesthesia

Beyond the preview

Go deeper on IRCT20201006048947N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20201006048947N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call